WallStSmart

DaVita HealthCare Partners Inc (DVA)vsPalantir Technologies Inc. (PLTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 161% more annual revenue ($13.64B vs $5.22B). PLTR leads profitability with a 43.7% profit margin vs 5.5%. DVA appears more attractively valued with a PEG of 0.58. PLTR earns a higher WallStSmart Score of 73/100 (B).

DVA

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 8.0Quality: 4.3
Piotroski: 3/9Altman Z: 1.22

PLTR

Strong Buy

73

out of 100

Grade: B

Growth: 10.0Profit: 9.5Value: 2.0Quality: 9.0
Piotroski: 5/9Altman Z: 4.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DVAUndervalued (+44.1%)

Margin of Safety

+44.1%

Fair Value

$257.96

Current Price

$198.65

$59.31 discount

UndervaluedFair: $257.96Overvalued
PLTRSignificantly Overvalued (-63.7%)

Margin of Safety

-63.7%

Fair Value

$78.69

Current Price

$137.80

$59.11 premium

UndervaluedFair: $78.69Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DVA2 strengths · Avg: 9.0/10
Return on EquityProfitability
64.8%10/10

Every $100 of equity generates 65 in profit

PEG RatioValuation
0.588/10

Growing faster than its price suggests

PLTR6 strengths · Avg: 10.0/10
Market CapQuality
$328.55B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
32.6%10/10

Every $100 of equity generates 33 in profit

Profit MarginProfitability
43.7%10/10

Keeps 44 of every $100 in revenue as profit

Operating MarginProfitability
46.2%10/10

Strong operational efficiency at 46.2%

Revenue GrowthGrowth
84.7%10/10

Revenue surging 84.7% year-over-year

EPS GrowthGrowth
325.0%10/10

Earnings expanding 325.0% YoY

Areas to Watch

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

PLTR3 concerns · Avg: 2.0/10
PEG RatioValuation
2.902/10

Expensive relative to growth rate

P/E RatioValuation
154.0x2/10

Premium valuation, high expectations priced in

Price/BookValuation
44.6x2/10

Trading at 44.6x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, PEG Ratio. PEG of 0.58 suggests the stock is reasonably priced for its growth.

Bull Case : PLTR

The strongest argument for PLTR centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 43.7% and operating margin at 46.2%. Revenue growth of 84.7% demonstrates continued momentum.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Bear Case : PLTR

The primary concerns for PLTR are PEG Ratio, P/E Ratio, Price/Book. A P/E of 154.0x leaves little room for execution misses.

Key Dynamics to Monitor

DVA profiles as a value stock while PLTR is a growth play — different risk/reward profiles.

PLTR carries more volatility with a beta of 1.52 — expect wider price swings.

PLTR is growing revenue faster at 84.7% — sustainability is the question.

PLTR generates stronger free cash flow (892M), providing more financial flexibility.

Bottom Line

PLTR scores higher overall (73/100 vs 66/100), backed by strong 43.7% margins and 84.7% revenue growth. DVA offers better value entry with a 44.1% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Palantir Technologies Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Palantir Technologies Inc. creates and implements software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company is headquartered in Denver, Colorado.

Visit Website →

Want to dig deeper into these stocks?